The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease that has spurred […]
Biogen Inc
Trending topics and news from the Biogen Inc category
Back to news homeAlzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense
In addition to the United States, Biogen has asked regulators in Australia, Brazil, Canada, the European Union, Japan and Switzerland to review the drug.The U.S. approval is a crucial victory […]